Experts believe the use of a drug for menstrual bleeding treatment could be used to treat severe injuries, specifically for soldiers. Tranexamic acid (TXA) is used to treat women with heavy menstrual bleeding. Experts suggest this drug may be used to prevent or slow bleeding for wounded solders, potentially saving nearly 10 percent of injured soldiers and civilians.
The drug is effective as it stabilizes a protein to help blood clot. The Food and Drug Administration (FDA) approved Lysteda (tranexamic acid) as a treatment for women experiencing heavy menstrual flow.
In new studies, tranexamic acid has been found to reduce death risks from blood loss in nearly 10 percent of cases when compared to individuals who do not have any treatment.
A symptom causing upwards of three million deaths per year, heavy bleeding may be somewhat preventable thanks to this drug.
Doctors have been recommending tranexamic acid be added to World Health Organization’s list of essential drugs for over a year.
The drug has shown very few negative side effects, and the benefits could save tens or hundreds of thousands of lives each year.
Experts explain this to be a very effective treatment option for soldiers.